Page 40 - 中国全科医学2022-09
P. 40
http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·1061·
10.2337/dc14-2441. [14]LIU D,JIN B,CHEN W,et al. Dipeptidyl peptidase 4 (DPP-
[4]中华医学会糖尿病学分会 . 中国 2 型糖尿病防治指南(2020 年 4) inhibitors and cardiovascular outcomes in patients with type
版)[J]. 中华糖尿病杂志,2021,13(4):315-409. DOI: 2 diabetes mellitus (T2DM):a systematic review and meta-
10.3760/cma.j.cn115791-20210221-00095. analysis[J]. BMC Pharmacol Toxicol,2019,20(1):15.
Chinese Diabetes Society. Guideline for the prevention and treatment DOI:10.1186/s40360-019-0293-y.
of type 2 diabetes mellitus in China(2020 edition)[J]. Chinese [15]ZENG D K,XIAO Q,LI F Q,et al. Cardiovascular risk of
Journal of Diabetes Mellitus,2021,13(4):315-409. DOI: sitagliptin in treating patients with type 2 diabetes mellitus[J].
10.3760/cma.j.cn115791-20210221-00095. Biosci Rep,2019,39(7):BSR20190980. DOI:
[5]WORKGROUP ON HYPOGLYCEMIA A D A. Defining and reporting 10.1042/BSR20190980.
hypoglycemia in diabetes:a report from the American Diabetes [16]CONSENSUS CONFERENCE PANEL,WATSON N F,BADR M
Association Workgroup on Hypoglycemia[J]. Diabetes Care, S,et al. Joint consensus statement of the American academy of sleep
2005,28(5):1245-1249. DOI:10.2337/diacare.28.5.1245. medicine and sleep research society on the recommended amount of
[6]AUSTIN P C. The use of propensity score methods with survival or sleep for a healthy adult:methodology and discussion[J]. J Clin
time-to-event outcomes:reporting measures of effect similar to those Sleep Med,2015,11(8):931-952. DOI:10.5664/jcsm.4950.
used in randomized experiments[J]. Stat Med,2014,33(7):
[17]KNUTSON K L,VAN CAUTER E. Associations between sleep
1242-1258. DOI:10.1002/sim.5984.
loss and increased risk of obesity and diabetes[J]. Ann N Y Acad
[7]HAVILAND A,NAGIN D S,ROSENBAUM P R. Combining
Sci,2008,1129:287-304. DOI:10.1196/annals.1417.033.
propensity score matching and group-based trajectory analysis in an
[18]SPIEGEL K,LEPROULT R,VAN CAUTER E. Impact of sleep
observational study[J]. Psychol Methods,2007,12(3):247-
debt on metabolic and endocrine function[J]. Lancet,1999,
267. DOI:10.1037/1082-989X.12.3.247.
354(9188):1435-1439. DOI:10.1016/S0140-6736(99)
[8]LIU Z J,ZHAO X D,SUN W W,et al. Metformin combined with
01376-8.
acarbose vs. single medicine in the treatment of type 2 diabetes:a
[19]SPIEGEL K,TASALI E,PENEV P,et al. Brief communication:
meta-analysis[J]. Exp Ther Med,2017,13(6):3137-3145.
sleep curtailment in healthy young men is associated with decreased
DOI:10.3892/etm.2017.4333.
leptin levels,elevated ghrelin levels,and increased hunger and
[9]HOLLANDER P,SUGIMOTO D,VLAJNIC A,et al. Combination
appetite[J]. Ann Intern Med,2004,141(11):846-850.
therapy with insulin glargine plus metformin but not insulin glargine
DOI:10.7326/0003-4819-141-11-200412070-00008.
plus sulfonylurea provides similar glycemic control to triple oral
[20]JHA P,RAMASUNDARAHETTIGE C,LANDSMAN V,et al.
combination therapy in patients with type 2 diabetes uncontrolled with
21st-century hazards of smoking and benefits of cessation in the
dual oral agent therapy[J]. J Diabetes Complications,2015,29(8):
United States[J]. N Engl J Med,2013,368(4):341-350.
1266-1271. DOI:10.1016/j.jdiacomp.2015.05.022.
DOI:10.1056/NEJMsa1211128.
[10]MARÍN-PEÑALVER J J,MARTÍN-TIMÓN I,DEL CAÑIZO-
[21]DUNCAN M S,FREIBERG M S,GREEVY R A Jr,et al.
GÓMEZ F J. Management of hospitalized type 2 diabetes mellitus
Association of smoking cessation with subsequent risk of cardiovascular
patients[J]. J Transl Int Med,2016,4(4):155-161. DOI:
disease[J]. JAMA,2019,322(7):642-650. DOI:
10.1515/jtim-2016-0027.
10.1001/jama.2019.10298.
[11]HOME P,ITZHAK B. Is insulin therapy safe? [J]. Am J Ther,
[22]CHAMBERLAIN J J,JOHNSON E L,LEAL S,et al.
2020,27(1):e106-114. DOI:10.1097/mjt.0000000000001077.
Cardiovascular disease and risk management:review of the
[12]HOLLANDER P,SUGIMOTO D,VLAJNIC A,et al. Combination
American diabetes association standards of medical care in diabetes
therapy with insulin glargine plus metformin but not insulin glargine
plus sulfonylurea provides similar glycemic control to triple oral 2018[J]. Ann Intern Med,2018,168(9):640-650. DOI:
combination therapy in patients with type 2 diabetes uncontrolled with 10.7326/M18-0222.
dual oral agent therapy[J]. J Diabetes Complications,2015,29(8): [23]AL-DELAIMY W K,MANSON J E,SOLOMON C G,et al.
1266-1271. DOI:10.1016/j.jdiacomp.2015.05.022. Smoking and risk of coronary heart disease among women with type 2
[13]HERMAN M E,O'KEEFE J H,BELL D S H,et al. Insulin diabetes mellitus[J]. Arch Intern Med,2002,162(3):273-
therapy increases cardiovascular risk in type 2 diabetes[J]. Prog 279. DOI:10.1001/archinte.162.3.273.
Cardiovasc Dis,2017,60(3):422-434. DOI:10.1016/j. (收稿日期:2021-11-22;修回日期:2022-01-10)
pcad.2017.09.001. (本文编辑:毛亚敏)